Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale 10% owner sold 18,746 shares at an average $35.50 ($665,439)
  6. 4 Open-market sale Director sold 40,000 shares at an average $32.64 ($1,305,506)
  7. 4 Open-market sale 10% owner sold 100 shares at $35.00 ($3,500)
  8. 4 Open-market sale 10% owner sold 11,876 shares at an average $35.44 ($420,892)
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 4 Open-market sale 10% owner sold 1,011 shares at $35.03 ($35,415)
  12. 4 Open-market sale 10% owner sold 7,138 shares at an average $35.14 ($250,803)
  13. 4 Open-market sale 10% owner sold 33,992 shares at an average $37.00 ($1,257,849)
  14. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $37.84 ($548,656)
  15. 8-K Event Other events
  16. 4 Open-market sale Director sold 40,000 shares at an average $36.55 ($1,462,089)
  17. DEFA14A Proxy Proxy Materials
  18. DEF 14A Proxy Proxy Statement
  19. SC 13D/A Stake Beneficial Ownership Report
  20. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $36.63 ($531,102)

Page 19 of 25 · 496 filings